MAR-mediated integration of plasmid vectors for in vivo gene transfer and regulation

BMC Molecular Biology

Nicolas Mermod¹  Andrzej J Kulik²  Deborah Ley⁴  Florence Hogger⁴  Małgorzata Lekka³  Damien Saugy⁴  Ruthger W van Zwieten⁴  Stefania Puttini⁴ 

[1] Laboratory for Molecular Biotechnology, Station 6, EPFL, 1015 Lausanne, Switzerland;Laboratory of Physics of Living Matter - IPSB, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland;The Henryk Niewodniczański Institute of Nuclear Physics, Polish Academy of Sciences, Kraków, Poland;Institute of Biotechnology, University of Lausanne, Lausanne, Switzerland

关键词: Gene therapy;    Utrophin;    Erythropoietin;    MAR elements;    Non-viral vectors;    Inducible expression;   

Others  :  797867
DOI  :  10.1186/1471-2199-14-26

 received in 2013-08-16, accepted in 2013-11-20,  发布年份 2013

【 摘 要 】

Background

The in vivo transfer of naked plasmid DNA into organs such as muscles is commonly used to assess the expression of prophylactic or therapeutic genes in animal disease models.

Results

In this study, we devised vectors allowing a tight regulation of transgene expression in mice from such non-viral vectors using a doxycycline-controlled network of activator and repressor proteins. Using these vectors, we demonstrate proper physiological response as consequence of the induced expression of two therapeutically relevant proteins, namely erythropoietin and utrophin. Kinetic studies showed that the induction of transgene expression was only transient, unless epigenetic regulatory elements termed Matrix Attachment Regions, or MAR, were inserted upstream of the regulated promoters. Using episomal plasmid rescue and quantitative PCR assays, we observed that similar amounts of plasmids remained in muscles after electrotransfer with or without MAR elements, but that a significant portion had integrated into the muscle fiber chromosomes. Interestingly, the MAR elements were found to promote plasmid genomic integration but to oppose silencing effects in vivo, thereby mediating long-term expression.

Conclusions

This study thus elucidates some of the determinants of transient or sustained expression from the use of non-viral regulated vectors in vivo.

【 授权许可】

   
2013 Puttini et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 5.

【 参考文献 】

• [1]Gossen M, Bujard H: Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 1992, 89(12):5547-5551.
• [2]Samakoglu S, Bohl D, Heard JM: Mechanisms leading to sustained reversion of beta-thalassemia in mice by doxycycline-controlled Epo delivery from muscles. Mol Ther 2002, 6(6):793-803.
• [3]Rendahl KG, Leff SE, Otten GR, Spratt SK, Bohl D, Van Roey M, Donahue BA, Cohen LK, Mandel RJ, Danos O, et al.: Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nat Biotechnol 1998, 16(8):757-761.
• [4]Rizzuto G, Cappelletti M, Maione D, Savino R, Lazzaro D, Costa P, Mathiesen I, Cortese R, Ciliberto G, Laufer R, et al.: Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc Natl Acad Sci U S A 1999, 96(11):6417-6422.
• [5]Freundlieb S, Schirra-Muller C, Bujard H: A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J Gene Med 1999, 1(1):4-12.
• [6]Imhof MO, Chatellard P, Mermod N: A regulatory network for the efficient control of transgene expression. J Gene Med 2000, 2(2):107-116.
• [7]Rossi FM, Guicherit OM, Spicher A, Kringstein AM, Fatyol K, Blakely BT, Blau HM: Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16. Nat Genet 1998, 20(4):389-393.
• [8]Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W: Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci U S A 2000, 97(14):7963-7968.
• [9]Imhof MO, Chatellard P, Mermod N: Comparative study and identification of potent eukaryotic transcriptional repressors in gene switch systems. J Biotechnol 2002, 97(3):275-285.
• [10]Girod PA, Nguyen DQ, Calabrese D, Puttini S, Grandjean M, Martinet D, Regamey A, Saugy D, Beckmann JS, Bucher P, et al.: Genome-wide prediction of matrix attachment regions that increase gene expression in mammalian cells. Nat Methods 2007, 4(9):747-753.
• [11]Lamartina S, Silvi L, Roscilli G, Casimiro D, Simon AJ, Davies ME, Shiver JW, Rinaudo CD, Zampaglione I, Fattori E, et al.: Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primates. Mol Ther 2003, 7(2):271-280.
• [12]Favre D, Blouin V, Provost N, Spisek R, Porrot F, Bohl D, Marme F, Cherel Y, Salvetti A, Hurtrel B, et al.: Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus. J Virol 2002, 76(22):11605-11611.
• [13]Latta-Mahieu M, Rolland M, Caillet C, Wang M, Kennel P, Mahfouz I, Loquet I, Dedieu JF, Mahfoudi A, Trannoy E, et al.: Gene transfer of a chimeric trans-activator is immunogenic and results in short-lived transgene expression. Hum Gene Ther 2002, 13(13):1611-1620.
• [14]Baum C, von Kalle C, Staal FJ, Li Z, Fehse B, Schmidt M, Weerkamp F, Karlsson S, Wagemaker G, Williams DA: Chance or necessity? Insertional mutagenesis in gene therapy and its consequences. Mol Ther 2004, 9(1):5-13.
• [15]Tan PH, Tan PL, George AJ, Chan CL: Gene therapy for transplantation with viral vectors–how much of the promise has been realised? Expert Opin Biol Ther 2006, 6(8):759-772.
• [16]Wang Z, Zhu T, Qiao C, Zhou L, Wang B, Zhang J, Chen C, Li J, Xiao X: Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol 2005, 23(3):321-328.
• [17]Gregorevic P, Blankinship MJ, Allen JM, Crawford RW, Meuse L, Miller DG, Russell DW, Chamberlain JS: Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 2004, 10(8):828-834.
• [18]Yan Z, Zhang Y, Duan D, Engelhardt JF: Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy. Proc Natl Acad Sci U S A 2000, 97(12):6716-6721.
• [19]Andre FM ML: Nucleic acids electrotransfer in vivo: mechanisms and practical aspects. Curr Gene Ther 2010, 4:267-280.
• [20]Daud AI, Mirza N, Lenox B, Andrews S, Urbas P, Gao GX, Lee JH, Sondak VK, Riker AI, Deconti RC, et al.: Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor. J Clin Oncol 2008, 26(19):3235-3241.
• [21]Margolin JF, Friedman JR, Meyer WK, Vissing H, Thiesen HJ, Rauscher FJ 3rd: Kruppel-associated boxes are potent transcriptional repression domains. Proc Natl Acad Sci U S A 1994, 91(10):4509-4513.
• [22]Han K, Manley JL: Transcriptional repression by the Drosophila even-skipped protein: definition of a minimal repression domain. Genes Dev 1993, 7(3):491-503.
• [23]Ayer DE, Laherty CD, Lawrence QA, Armstrong AP, Eisenman RN: Mad proteins contain a dominant transcription repression domain. Mol Cell Biol 1996, 16(10):5772-5781.
• [24]Wang F, Koyama N, Nishida H, Haraguchi T, Reith W, Tsukamoto T: The assembly and maintenance of heterochromatin initiated by transgene repeats are independent of the RNA interference pathway in mammalian cells. Mol Cell Biol 2006, 26(11):4028-4040.
• [25]Squire S, Raymackers JM, Vandebrouck C, Potter A, Tinsley J, Fisher R, Gillis JM, Davies KE: Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system. Hum Mol Genet 2002, 11(26):3333-3344.
• [26]Gilbert R, Liu A, Petrof B, Nalbantoglu J, Karpati G: Improved performance of a fully gutted adenovirus vector containing two full-length dystrophin cDNAs regulated by a strong promoter. Mol Ther 2002, 6(4):501-509.
• [27]Dickson G, Roberts ML, Wells DJ, Fabb SA: Recombinant micro-genes and dystrophin viral vectors. Neuromuscul Disord 2002, 12(Suppl 1):S40-S44.
• [28]McMahon JM, Signori E, Wells KE, Fazio VM, Wells DJ: Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase – increased expression with reduced muscle damage. Gene Ther 2001, 8(16):1264-1270.
• [29]Puttini S, Lekka M, Dorchies OM, Saugy D, Incitti T, Ruegg UT, Bozzoni I, Kulik AJ, Mermod N: Gene-mediated restoration of normal myofiber elasticity in dystrophic muscles. Mol Ther 2009, 17(1):19-25.
• [30]Girod PA, Zahn-Zabal M, Mermod N: Use of the chicken lysozyme 5′ matrix attachment region to generate high producer CHO cell lines. Biotechnol Bioeng 2005, 91(1):1-11.
• [31]Grandjean M, Girod PA, Calabrese D, Kostyrko K, Wicht M, Yerly F, Mazza C, Beckmann JS, Martinet D, Mermod N: High-level transgene expression by homologous recombination-mediated gene transfer. Nucleic Acids Res 2011, 39(15):e104.
• [32]Harraghy N, Gaussin A, Mermod N: Sustained transgene expression using MAR elements. Curr Gene Ther 2008, 8(5):353-366.
• [33]Galbete JL, Buceta M, Mermod N: MAR elements regulate the probability of epigenetic switching between active and inactive gene expression. Mol Biosyst 2009, 5(2):143-150.
• [34]Penaud-Budloo M, Le Guiner C, Nowrouzi A, Toromanoff A, Cherel Y, Chenuaud P, Schmidt M, von Kalle C, Rolling F, Moullier P, et al.: Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle. J Virol 2008, 82(16):7875-7885.
• [35]Schnepp BC, Jensen RL, Chen CL, Johnson PR, Clark KR: Characterization of adeno-associated virus genomes isolated from human tissues. J Virol 2005, 79(23):14793-14803.
• [36]Schnepp BC, Jensen RL, Clark KR, Johnson PR: Infectious molecular clones of adeno-associated virus isolated directly from human tissues. J Virol 2009, 83(3):1456-1464.
• [37]Manam S, Ledwith BJ, Barnum AB, Troilo PJ, Pauley CJ, Harper LB, Griffiths TG 2nd, Niu Z, Denisova L, Follmer TT, et al.: Plasmid DNA vaccines: tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA. Intervirology 2000, 43(4–6):273-281.
• [38]Wang Z, Troilo PJ, Wang X, Griffiths TG, Pacchione SJ, Barnum AB, Harper LB, Pauley CJ, Niu Z, Denisova L, et al.: Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation. Gene Ther 2004, 11(8):711-721.
• [39]Riu E, Chen ZY, Xu H, He CY, Kay MA: Histone modifications are associated with the persistence or silencing of vector-mediated transgene expression in vivo. Mol Ther 2007, 15(7):1348-1355.
• [40]Chen ZY, He CY, Ehrhardt A, Kay MA: Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol Ther 2003, 8(3):495-500.
• [41]Niwa H, Yamamura K, Miyazaki J: Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991, 108(2):193-199.
• [42]Seipel K, Georgiev O, Schaffner W: Different activation domains stimulate transcription from remote (‘enhancer’) and proximal (‘promoter’) positions. EMBO J 1992, 11(13):4961-4968.
• [43]Karlen Y, McNair A, Perseguers S, Mazza C, Mermod N: Statistical significance of quantitative PCR. BMC Bioinforma 2007, 8:131. BioMed Central Full Text